IL145719A0 - Polypeptides encoded by nucleotide sequences expressed in breast tumor tissue and uses thereof - Google Patents
Polypeptides encoded by nucleotide sequences expressed in breast tumor tissue and uses thereofInfo
- Publication number
- IL145719A0 IL145719A0 IL14571900A IL14571900A IL145719A0 IL 145719 A0 IL145719 A0 IL 145719A0 IL 14571900 A IL14571900 A IL 14571900A IL 14571900 A IL14571900 A IL 14571900A IL 145719 A0 IL145719 A0 IL 145719A0
- Authority
- IL
- Israel
- Prior art keywords
- nucleotide sequences
- tumor tissue
- breast tumor
- polypeptides encoded
- sequences expressed
- Prior art date
Links
- 206010006187 Breast cancer Diseases 0.000 title 1
- 208000026310 Breast neoplasm Diseases 0.000 title 1
- 108091028043 Nucleic acid sequence Proteins 0.000 title 1
- 229920001184 polypeptide Polymers 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/515—Animal cells
- A61K2039/5154—Antigen presenting cells [APCs], e.g. dendritic cells or macrophages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/289,198 US6586570B1 (en) | 1996-01-11 | 1999-04-09 | Compositions and methods for the treatment and diagnosis of breast cancer |
US09/429,755 US6656480B2 (en) | 1996-01-11 | 1999-10-28 | Compositions and methods for the treatment and diagnosis of breast cancer |
US09/534,825 US6861506B1 (en) | 1996-01-11 | 2000-03-23 | Compositions and methods for the treatment and diagnosis of breast cancer |
PCT/US2000/009312 WO2000061753A2 (en) | 1999-04-09 | 2000-04-07 | Compositions and methods for the treatment and diagnosis of breast cancer |
Publications (1)
Publication Number | Publication Date |
---|---|
IL145719A0 true IL145719A0 (en) | 2002-07-25 |
Family
ID=27403868
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL14571900A IL145719A0 (en) | 1999-04-09 | 2000-04-07 | Polypeptides encoded by nucleotide sequences expressed in breast tumor tissue and uses thereof |
Country Status (15)
Country | Link |
---|---|
EP (1) | EP1169444A2 (no) |
JP (1) | JP2002541803A (no) |
KR (1) | KR20020026418A (no) |
CN (1) | CN1352683A (no) |
AU (1) | AU774824B2 (no) |
BR (1) | BR0009573A (no) |
CA (1) | CA2365909A1 (no) |
CZ (1) | CZ20013575A3 (no) |
HU (1) | HUP0200825A2 (no) |
IL (1) | IL145719A0 (no) |
MX (1) | MXPA01010186A (no) |
NO (1) | NO20014805L (no) |
NZ (1) | NZ514646A (no) |
PL (1) | PL350863A1 (no) |
WO (1) | WO2000061753A2 (no) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020068285A1 (en) * | 1996-01-11 | 2002-06-06 | Frudakis Tony N. | Compositions and methods for the therapy and diagnosis of breast cancer |
US20030125536A1 (en) * | 1996-01-11 | 2003-07-03 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of breast cancer |
US6656480B2 (en) | 1996-01-11 | 2003-12-02 | Corixa Corporation | Compositions and methods for the treatment and diagnosis of breast cancer |
US7241876B2 (en) | 1996-01-11 | 2007-07-10 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of breast cancer |
US6861506B1 (en) | 1996-01-11 | 2005-03-01 | Corixa Corporation | Compositions and methods for the treatment and diagnosis of breast cancer |
US6828431B1 (en) | 1999-04-09 | 2004-12-07 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of breast cancer |
US6586570B1 (en) | 1996-01-11 | 2003-07-01 | Corixa Corporation | Compositions and methods for the treatment and diagnosis of breast cancer |
AU2003243151A1 (en) | 2002-08-16 | 2004-03-03 | Agensys, Inc. | Nucleic acid and corresponding protein entitled 251p5g2 useful in treatment and detection of cancer |
CN111983220B (zh) * | 2019-05-21 | 2024-03-19 | 北京中科纳泰生物科技有限公司 | 多肽磁性纳米颗粒、其制备方法及应用 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1211279A (zh) * | 1996-01-10 | 1999-03-17 | 科里克萨有限公司 | 用于治疗和诊断乳腺癌的组合物和方法 |
WO1997025431A1 (en) * | 1996-01-10 | 1997-07-17 | Corixa Corporation | Compositions and methods for the treatment and diagnosis of cancer |
ZA982968B (en) * | 1997-04-09 | 1998-10-27 | Corixa Corp | Compositions and methods for the treatment and diagnosis of breast cancer |
ATE440951T1 (de) * | 1997-12-17 | 2009-09-15 | Serono Genetics Inst Sa | Verlängerte cdns, die für sekretierte proteine kodieren |
CA2334038A1 (en) * | 1998-07-14 | 2000-01-27 | Corixa Corporation | Compositions and methods for therapy and diagnosis of prostate cancer |
-
2000
- 2000-04-07 KR KR1020017012887A patent/KR20020026418A/ko not_active Application Discontinuation
- 2000-04-07 AU AU42130/00A patent/AU774824B2/en not_active Ceased
- 2000-04-07 HU HU0200825A patent/HUP0200825A2/hu unknown
- 2000-04-07 CN CN00807022A patent/CN1352683A/zh active Pending
- 2000-04-07 PL PL00350863A patent/PL350863A1/xx not_active IP Right Cessation
- 2000-04-07 EP EP00921869A patent/EP1169444A2/en not_active Withdrawn
- 2000-04-07 CA CA002365909A patent/CA2365909A1/en not_active Abandoned
- 2000-04-07 MX MXPA01010186A patent/MXPA01010186A/es not_active Application Discontinuation
- 2000-04-07 JP JP2000611676A patent/JP2002541803A/ja active Pending
- 2000-04-07 BR BR0009573-7A patent/BR0009573A/pt not_active Application Discontinuation
- 2000-04-07 CZ CZ20013575A patent/CZ20013575A3/cs unknown
- 2000-04-07 IL IL14571900A patent/IL145719A0/xx unknown
- 2000-04-07 NZ NZ514646A patent/NZ514646A/en not_active IP Right Cessation
- 2000-04-07 WO PCT/US2000/009312 patent/WO2000061753A2/en active Application Filing
-
2001
- 2001-10-03 NO NO20014805A patent/NO20014805L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AU4213000A (en) | 2000-11-14 |
WO2000061753A2 (en) | 2000-10-19 |
HUP0200825A2 (en) | 2002-07-29 |
EP1169444A2 (en) | 2002-01-09 |
MXPA01010186A (es) | 2004-08-12 |
PL350863A1 (en) | 2003-02-10 |
NO20014805D0 (no) | 2001-10-03 |
CN1352683A (zh) | 2002-06-05 |
NZ514646A (en) | 2005-04-29 |
JP2002541803A (ja) | 2002-12-10 |
NO20014805L (no) | 2001-12-06 |
KR20020026418A (ko) | 2002-04-10 |
BR0009573A (pt) | 2002-04-16 |
CZ20013575A3 (cs) | 2002-10-16 |
AU774824B2 (en) | 2004-07-08 |
CA2365909A1 (en) | 2000-10-19 |
WO2000061753A3 (en) | 2001-06-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU3619400A (en) | Human prostate cancer associated gene sequences and polypeptides | |
EP1076090A2 (en) | ESTs and encoded human proteins | |
AU7680300A (en) | Human dna sequences | |
EP1330543A4 (en) | IN CANCER TISSUE, EXPRESSED NUCLEIC ACID SEQUENCES DIFFERENTIATE | |
GB0021259D0 (en) | Water treatment | |
MXPA02011517A (es) | Uso de vectores de baculovirus en terapia genetica. | |
IL206604A0 (en) | Transmembrane protein expressed in prostate cancer | |
EP1141301A4 (en) | DNA FRAGMENTS DETERMINED ACCORDING TO THEIR SEQUENCE AND CORRESPONDING POLYPEPTIDES CODED BY SAID FRAGMENTS | |
IL145719A0 (en) | Polypeptides encoded by nucleotide sequences expressed in breast tumor tissue and uses thereof | |
EP1210416A4 (en) | GENES CODING PROTEINS FOR DIAGNOSTIC, PREVENTIVE AND THERAPEUTIC USE | |
HK1042504A1 (en) | Human cervical cancer 1 protooncogene and protein encoded therein | |
AU2890199A (en) | Gata-3-expression in human breast carcinoma | |
EP1148238A4 (en) | SEMI-SPHERICAL SHOE | |
IL152847A0 (en) | Polypeptides containing at least a portion of a breast tumor protein, polynucleotides encoding the same and diagnostic methods utilizing the same | |
AU2003228431A8 (en) | Hmgn2 peptides and related melecules that selectively home to tumor blood vessels and tumor cells | |
EP1218392A4 (en) | GENE THE PROTEINS ENCODE WHICH PROGNOSTIC, DIAGNOSTIC, PREVENTIVE, THERAPEUTIC AND OTHER USE HAVE | |
EP1148236A4 (en) | HALF BALL SHOE | |
EP1401494A4 (en) | TUMOR THERAPY | |
GB9929694D0 (en) | Water treatment | |
AU2003279100A8 (en) | Peptide nucleic acids having improved uptake and tissue distribution | |
EP1194534A4 (en) | NOVEL GENES ENCODING PROTEINS THAT CAN BE USED IN DIAGNOSTIC, PREVENTIVE, THERAPEUTIC OR OTHER AREAS | |
NZ513739A (en) | Cloning of cDNA of mage's 5, 8, 9 and 11 and their uses in diagnosis of cancer | |
GB2356437B (en) | Improvements in swashplate design | |
GB0210912D0 (en) | Sequences encoding human neoplastic marker | |
AU1926699A (en) | Cathepsin dc proteins, dna encoding the proteins, and their use in human cancer prognosis |